Endo International to Pay Up to $600 Million for Dava, a Generic Drug Maker CHAD BRAY Endo, based in Dublin, said it would pay $575 million in cash for the privately held Dava Pharmaceuticals of Fort Lee, N.J., and up to an additional $25 million based on sales milestones. June 24, 2014 at 4:00AM http://nyti.ms/1yJCIQb The New York Times Business Day Drugs (Pharmaceuticals), Generic Brands and Products, Mergers, Acquisitions and Divestitures

By CHAD BRAY via NYT / Eethg. Corps. Inc. / Terrence Herschel G. Business Day http://nyti.ms/1yJCIQb Endo International to Pay Up to $600 Million for Dava, a Generic Drug Maker June 24, 2014 at 4:00AM The New York Times